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Neurologic signs and symptoms are common in
acute malarial infection. However, after the parasites
have been cleared from the blood or after patients 
of cerebral malaria have fully recovered from their
consciousness disturbance, the neurologic or psy-
chiatric symptoms may occur or recur within 2
months after the acute illness. This phenomenon is
called “postmalaria neurologic syndrome” (PMNS).
We present our experience of managing such a
patient.
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Neurologic signs and symptoms are common in acute malarial infection. However, after the par-
asites have been cleared from the blood and patients recover full consciousness, neurologic or
psychiatric symptoms may occur or recur within 2 months after the acute illness. This phenome-
non is called “postmalaria neurologic syndrome” (PMNS). We present a 50-year-old man who
returned from the Republic of Malawi and soon developed Plasmodium falciparum malaria. Cerebral
malaria, renal failure, hepatic failure, diffuse intravascular coagulation with thrombocytopenia,
and upper gastrointestinal bleeding were noted during the acute stage. He was admitted to the
infectious diseases ward and treated for 3 weeks. He was free from clinical general symptoms
and parasites in blood smear when discharged. However, 2 weeks after discharge, he began to
experience severe headache, dizziness, diplopia, mild hand tremor, unsteady gait, and easy falling.
When readmitted to the neurologic ward, he presented with irritability, delirium, visual halluci-
nation, and strange behavior. Neurologic examination was normal except for mild general weak-
ness and evident truncal ataxia when walking. Brain magnetic resonance imaging revealed no
structural lesions, and electroencephalography showed diffuse cortical dysfunction. Cerebral
spinal fluid profile exhibited cytoalbuminologic dissociation. Brain single photon emission com-
puted tomography showed diffuse cerebral parenchymal disorder. Nerve conduction studies
revealed early sensory predominant polyneuropathy. The unsteadiness persisted for the initial 
2 weeks of hospitalization until corticosteroid was administered. Intravenous methylprednisolone
(80 mg/day) was continued for 3 days, followed by oral prednisolone (45 mg/day). His unsteadi-
ness improved gradually after medication, and he absconded from the hospital on the 9th day 
of corticosteroid treatment with clear consciousness and free ambulation. The manifestation of
PMNS is diverse and may present as an acute confusional state or psychosis, generalized seizure,
fine tremors, cerebellar syndromes, postural hypotension, or malarial polyneuritis. Although the
neurologic syndrome is primarily self-limited in most cases, corticosteroid may be beneficial in
reversing PMNS.
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CASE PRESENTATION
A 50-year-old man lived in the Republic of Malawi as
a construction worker from October to December 2003.
On returning to Taiwan, he experienced fever and
chills and was hospitalized in our infectious diseases
ward from December 29, 2003 to January 20, 2004.
Plasmodium falciparum was observed in his blood
smear. Seizure occurred on January 1, 2004 and he was
comatose from January 6 to 13, 2004. Pneumonia,
acute renal failure, acute hepatic failure, dissemi-
nated intravascular coagulation with thrombocyto-
penia, and upper gastrointestinal bleeding further
complicated his clinical condition. After antibiotics
administration and supportive care, he completely
recovered and was discharged. Medications during
hospitalization included amoxicillin/sulbactam, lora-
tadine, ceftriaxone, clindamycin, ciprofloxacin, arte-
sunate, doxycycline, quinine, and mefloquine.
No obvious general or neurologic abnormalities
were noted on discharge except for slight malaise.
Two weeks later, he suffered from dizziness, severe
headache, horizontal diplopia, and mild hand tremor.
The dizziness was chronic and associated with an
unsteady gait and easy falling.
He was found lying outside his room in a hotel
with loss of consciousness on February 25, 2004 (3
weeks after his initial presentation of dizziness). He
was sent to our emergency room, where he was noted
to have elevated blood pressure (200/180 mmHg),
slight tachycardia (109 beats/minute), and normal
body temperature (36.4°C). Laboratory data showed
no obvious abnormality except for slight anemia
(hemoglobin, 13.2mg/dL). Irritability, delirium, visual
hallucination, and strange behavior were also found.
He was admitted under the impression of acute con-
sciousness loss and delirium.
Further neurologic examination revealed intact cra-
nial nerve function, although the patient complained
of intermittent double vision in all directions. Motor
function examination found mild general weakness.
Deep tendon reflexes were normal. Sensory examina-
tions revealed symmetric pin-prick pain and joint-
position sensation. Finger-nose-finger test revealed
no obvious dysmetria, but truncal ataxia was evident
when he walked.
Brain magnetic resonance imaging (MRI) showed
no structural lesions (Figure 1), and electroencephalo-
graphy showed diffuse cortical dysfunction. Cere-
bral spinal fluid profile revealed cytoalbuminologic
Figure 1. Brain magnetic resonance imaging shows no definite evidence of organic brain lesion.
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dissociation (open pressure, 140 mmH2O; cell counts,
0/mL3; glucose, 50 mg/dL; protein, 205 mg/dL). No
parasites were found in blood smear. Brain single
photon emission computed tomography (SPECT)
revealed diffuse cerebral parenchymal disorder (Figure
2). Nerve conduction studies showed early sensory
predominant polyneuropathy. Autonomic examina-
tions such as sympathetic skin response and RR
interval variation found impairment of sympathetic
and parasympathetic function. Brainstem auditory
evoked potentials were normal.
The unsteadiness persisted for the initial 2 weeks
of hospitalization until administration of cortico-
steroid. Intravenous methylprednisolone 80 mg/day
was administered for 3 days, followed by oral pred-
nisolone 45 mg/day. His unsteadiness improved
gradually after medication, and he absconded from
the hospital on the 9th day of corticosteroid treat-
ment with clear consciousness and free ambulation. 
A brief summary of the clinical course is shown in
Figure 3.
DISCUSSION
The manifestation of PMNS is diverse; it may present
as an acute confusional state or psychosis, generalized
seizure, fine tremors, cerebellar syndromes, postural
hypotension, brainstem dysfunction, or malarial
polyneuritis [1–3]. Our patient presented with severe
headache, dizziness, subjective diplopia (horizontal
or vertical), mild hand tremor, unsteady gait, easy
falling, delirium, polyneuropathy, and autonomic
dysfunction within 2 months after recovering from
cerebral malaria. His neurologic and psychiatric pre-
sentations were compatible with PMNS.
The mechanisms of PMNS remain unclear. The
possible mechanisms include the following: (1) cere-
bral parasitized erythrocyte sequestration; (2) immuno-
logic mechanism, such as acute disseminated
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Figure 3. The clinical course of the patient.
Figure 2. Tc-99m hexamethylpropylene amineoxime brain perfu-
sion single photon emission computed tomography shows markedly
decreased radioactivity in both cerebral hemispheres (sparing
cerebellar hemispheres), especially in bilateral temporal and parietal
lobes. The cerebral/cerebellar uptake ratio is approximately 0.5
(reduced from a normal value of about 1). Impression: decreased
perfusion involving the above sites. However, diffuse cerebral
parenchymal disease seems most likely.
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encephalomyelitis; (3) coinfection with a virus such
as Japanese B virus, herpes simplex virus, and Dengue
virus, which are capable of causing encephalitis; (4)
metabolic abnormalities such as hypoglycemia; and
(5) side effects of antimalaria drugs such as chloro-
quine, mefloquine, artemether, and artesunate [1,2,4].
The brain SPECT (Figure 2) of our patient revealed
markedly decreased radioactivity in both cerebral
hemispheres (sparing cerebellar hemispheres), espe-
cially in bilateral temporal and parietal lobes, which
indicated impaired cerebral microcirculation. Brain
SPECT findings of cerebral malaria have been re-
ported, and a reversible cerebral hypoperfusion and
decreased oxygenation pattern are usual [5]. The
cerebral hypoperfusion in our patient was presumed
to be the main factor contributing to PMNS. As there
is a strong association between mefloquine and the
development of PMNS, the use of mefloquine in our
patient may also have played a role in the PMNS [2].
Finally, the dramatic improvement of our patient’s
symptoms with corticosteroid therapy further sug-
gests an immunologic mechanism. Nevertheless, the
mechanisms of PMNS seem multifactorial, as in 
our case.
The unsteadiness of our patient was due to multi-
ple factors such as general weakness, delirium, truncal
ataxia, and autonomic dysfunction. Delayed cerebellar
ataxia has been reported as one delayed complication
of P. falciparum malaria [6–8]. This unusual com-
plication has acute onset of signs suggesting pre-
dominantly midline cerebellar lesions without any
evidence of cerebral involvement, and the lower limbs
are more often involved than the upper limbs [9]. Our
patient had truncal ataxia that could have been due 
to midline cerebellar involvement, but we were not
able to demonstrate the expected finding from brain
images. Although brain SPECT showed no midline
cerebellum hypoperfusion, cerebral hemispheres
hypoperfusion may indicate corticocerebellar path-
way involvement. In addition, cerebellar dysfunction
may not always demonstrate cerebellar hypoper-
fusion on brain SPECT. Brain SPECT may reveal
increased perfusion in both cerebellar hemispheres in
acute Epstein–Barr virus cerebellitis [10]. In Machado-
Joseph disease, severe cerebellar atrophy can some-
times be detected on brain MRI, but there is normal
regional cerebral flow on brain SPECT [11].
The neurologic syndrome is primarily self-limited
in most cases, with a median duration of 60 hours
(range, 24–240 hours) [2]. The majority of patients with
delayed cerebellar ataxia recover within 4 weeks, and
some require the use of corticosteroids for prompt
recovery [9]. The unsteadiness of our patient persisted
for 5 weeks until the use of corticosteroid, which
resulted in a dramatic recovery. The regimen of admin-
istering corticosteroid included: (1) prednisolone
(60 mg/day) for 1 week followed by gradually dimin-
ishing daily doses for another 4 days [3]; (2) methyl-
prednisolone sodium succinate (100 mg/day) for 3
days with subsequent tapering for 10 days [12]; and
(3) prednisolone (60 mg/day) for 4 days [12]. We
adjusted our regimen to methylprednisolone (80 mg/
day) for 3 days followed by prednisolone (45 mg/day)
for 6 days, whereupon prednisolone was discontin-
ued because the patient absconded from the hospital.
Corticosteroid is thought to be beneficial in PMNS,
but some have reported that corticosteroid might 
be harmful in cerebral malaria, increasing the risk 
of seizures and gastrointestinal hemorrhages [13].
However, there is insufficient evidence of contraindi-
cation of corticosteroids in cerebral malaria [13].
Malaria is typically found in tropical and subtro-
pical countries. Large areas of Central and South
America, Hispaniola (the Caribbean island that is
divided between Haiti and the Dominican Republic),
Africa, the Indian subcontinent, Southeast Asia, the
Middle East, and Oceania are malaria-risk areas. The
overall incidence of PMNS after falciparum malaria
was 1.2/1,000 (0.7–1.8 per 1,000) [2].
Taiwan has been free of malaria since 1965;
reported cases of malaria are primarily imported and
the case number is around 30 persons/year according
to the Center for Disease Control, Taiwan. Thus, there
is little chance of encountering patients with PMNS.
This case may be the first case report of PMNS in
Taiwan. As more Taiwanese go abroad to Africa and
Southeast Asia, more imported malaria cases are to
be expected. Clinicians should keep in mind that
PMNS may occur within 2 months in a patient with a
history of malaria. The syndrome is primarily self-
limited, but corticosteroid may be needed to hasten
recovery.
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